18 September 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

18 September 2017 | n=36

  1. Zoboli F, Ripamonti D, Benatti SV, Comi L, et al.
    Autoimmune hepatitis and HIV infection: two case reports and review of the literature.
    AIDS 2017;31:2172-2175.

  2. Hyle EP, Jani IV, Rosettie KL, Wood R, et al.
    The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
    AIDS 2017;31:2135-2145.

  3. Lake AC.
    Hepatitis B reactivation in a long-term nonprogressor due to nivolumab therapy.
    AIDS 2017;31:2115-2118.

  4. Gianella S, Chaillon A, Mutlu EA, Engen PA, et al.
    Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
    AIDS 2017;31:2059-2067.

  5. Gourlay AJ, Pharris AM, Noori T, Supervie V, et al.
    Towards standardized definitions for monitoring the continuum of HIV care in Europe.
    AIDS 2017;31:2053-2058.

  6. Tachibana S, Sasaki M, Tanaka T, Inoue M, et al.
    A 2-4-amino-acid deletion in the V5 region of HIV-1 Env gp120 confers viral resistance to the broadly neutralizing human monoclonal antibody, VRC01.
    AIDS Res Hum Retroviruses 2017.

  7. Mujugira A, Baeten J, Kidoguchi L, Haberer J, et al.
    High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy.
    AIDS Res Hum Retroviruses 2017.

  8. Williams B, Ghosh M, Boucher CAB, Bushman F, et al.
    A summary of the second annual HIV Microbiome workshop.
    AIDS Res Hum Retroviruses 2017.

  9. Fleury HJ, Tumiotto C, Bellecave P, Recordon-Pinson P, et al.
    Therapeutic vaccine against HIV, viral variability, CTL epitopes and genetics of patients.
    AIDS Res Hum Retroviruses 2017.

  10. Chimukangara B, Manasa J, Mitchell R, Nyabadza G, et al.
    Community Based Antiretroviral Treatment in Rural Zimbabwe.
    AIDS Res Hum Retroviruses 2017.

  11. Zhang A, Pan X, Wu F, Zhao Y, et al.
    'What Would an HIV Cure Mean to You?': Qualitative Analysis from a Crowdsourcing Contest in Guangzhou, China.
    AIDS Res Hum Retroviruses 2017.

  12. Kattakuzhy S, Gross C, Emmanuel B, Teferi G, et al.
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med 2017.

  13. Macias J, Mancebo M, Merino D, Tellez F, et al.
    Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
    Clin Infect Dis 2017;65:1012-1019.

  14. Trickey A, May MT, Schommers P, Tate J, et al.
    CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Clin Infect Dis 2017;65:959-966.

  15. .
    Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery: Erratum.
    J Acquir Immune Defic Syndr 2017;76:e64.

  16. Wilton J, Mishra S, Tan DHS.
    Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP.
    J Acquir Immune Defic Syndr 2017;76:e58-e61.

  17. Sandfort TGM, Knox JR, Alcala C, El-Bassel N, et al.
    Substance Use and HIV Risk Among Men Who Have Sex With Men in Africa: A Systematic Review.
    J Acquir Immune Defic Syndr 2017;76:e34-e46.

  18. Ferretti F, Mora-Peris B, Underwood J, Waldman A, et al.
    Cognitive Impairment in a Clinical Setting.
    J Acquir Immune Defic Syndr 2017.

  19. Eckard AR, O'Riordan MA, Rosebush JC, Ruff JH, et al.
    Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-infected Youth.
    J Acquir Immune Defic Syndr 2017.

  20. Zhang HL, Rhea SK, Hurt CB, Mobley VL, et al.
    HIV pre-exposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers.
    J Acquir Immune Defic Syndr 2017.

  21. Stoner MCD, Edwards JK, Miller WC, Aiello AE, et al.
    The effect of schooling on age-disparate relationships and number of sexual partners among young women in rural South Africa enrolled in HPTN 068.
    J Acquir Immune Defic Syndr 2017.

  22. Ondiek J, Namukaya Z, Mtapuri-Zinyowera S, Balkan S, et al.
    Multicountry Validation of SAMBA - A Novel Molecular Point-of-Care Test for HIV-1 Detection in Resource-Limited Setting.
    J Acquir Immune Defic Syndr 2017;76:e52-e57.

  23. Fabbiani M, Muscatello A, Perseghin P, Bani M, et al.
    Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients.
    J Acquir Immune Defic Syndr 2017;76:219-224.

  24. Smolders EJ, Smit C, T M M de Kanter C, Dofferiiof ASM, et al.
    Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.
    J Acquir Immune Defic Syndr 2017;76:193-199.

  25. Misra K, Udeagu CC.
    Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017.
    J Acquir Immune Defic Syndr 2017;76:132-140.

  26. Landovitz RJ, Beymer M, Kofron R, Amico KR, et al.
    Plasma Tenofovir-levels to Support Adherence to TDF/FTC Pre-exposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.
    J Acquir Immune Defic Syndr 2017.

  27. Firnhaber C, Swarts A, Goeieman B, Rakhombe N, et al.
    Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial.
    J Acquir Immune Defic Syndr 2017.

  28. Valverde EE, Oster AM, Xu S, Wertheim JO, et al.
    HIV Transmission Dynamics among Foreign-born Persons in the United States.
    J Acquir Immune Defic Syndr 2017.

  29. Plotzker R, Seekaew P, Jantarapakde J, Pengnonyang S, et al.
    The Importance of Risk Perception: Predictors of PrEP Acceptance Among Thai MSM and TG Women at a Community-Based Health Service.
    J Acquir Immune Defic Syndr 2017.

  30. Van Zyl GU, Katusiime MG, Wiegand A, McManus WR, et al.
    No evidence of HIV replication in children on antiretroviral therapy.
    J Clin Invest 2017.

  31. Ucciferri C, Tamburro M, Falasca K, Sammarco ML, et al.
    Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men.
    J Med Virol 2017.

  32. Bomsel M, Ganor Y.
    Calcitonin gene-related peptide induces HIV-1 proteasomal degradation in mucosal Langerhans cells.
    J Virol 2017.

  33. Teigler JE, Zelinskyy G, Eller MA, Bolton DL, et al.
    Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    J Virol 2017.

  34. Littwitz-Salomon E, Schimmer S, Dittmer U.
    The dose of retroviral infection determines the induction of anti-viral NK cell responses.
    J Virol 2017.

  35. Sulis G, Amadasi S, Odone A, Penazzato M, et al.
    Antiretroviral Therapy in HIV Infected Children with Tuberculosis: A Systematic Review.
    Pediatr Infect Dis J 2017.

  36. Siemieniuk RAC, Lytvyn L, Mah Ming J, Mullen RM, et al.
    Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline.
    BMJ 2017;358:j3961.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

16 July 2018

09 July 2018

02 July 2018

25 June 2018

18 June 2018

18 September 2017

Multidisciplinary Journal Club

  1. Sax PE, Pozniak A, Montes ML, Koenig E, et al.
    Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre%
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32340.

  2. Gallant J, Lazzarin A, Mills A, Orkin C, et al.
    Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-in
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32299.

  3. Corren J, Parnes JR, Wang L, Mo M, et al.
    Tezepelumab in Adults with Uncontrolled Asthma.
    N Engl J Med. 2017;377:936-946.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016